New data shows zigakibart sustains proteinuria remission and kidney function in IgA nephropathy
New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as...
proteinuria
SGLT2 inhibitors may be option for Fabry-related proteinuria: Study
SGLT2 inhibitors, medications approved for diabetes, could be used in Fabry disease to reduce albuminuria, which occurs when damaged kidneys...
